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male patients. Among the Gram-negative Escherichia coli
n = 337 presented the highest prevalence, followed by
Proteus mirabilis n = 97, Pseudomonas aeruginosa n = 67,
Candida species n = 65, Klebsiella pneumoniae n = 45 and
Acinetobacter baumannii n = 22. Among Gram positive iso-
lates Enterococcus faecalis was the most prevalence n = 28,
followed by coagulase negative staphylococci n = 16, Entero-
coccus faecium n = 11 and Staphylococcus aureus n = 5. They
were 4 VRE strains (Enterococcus faecium) in the urine. All
Gram positive cocci were sensitive to linezolide. Resistance
rates to Gram-negative are presented. All Gram-negative
were susceptible to colistin. All strains of Acinetobac-
ter baumannii were susceptible to doxycyclin while they
appeared susceptible to ampicillin/sulbactam to a percent-
age of 90%. The largest number of fungus positive samples
were taken from the Internal medicine departments
Conclusions: Escherichia coli is the primary bacterial
pathogen causing UTIs in nosocomial patients. Candida
albicans was isolated from the majority of the samples,
compared to non albicans.
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Impact of Educational Efforts on Antimicrobial Prescribing
and Bacterial Resistance Rates in a Community Hospital
O.H. DeTorres
Palomar Medical Center, Escondido, CA, USA
Purpose: The prescribing of quinolones in the outpa-
tient setting has resulted in widespread quinolone resistance
among gram-negative organisms. Because of this, quinolones
should no longer be used as empiric therapy in the manage-
ment of urinary tract infections within our hospitals. The
objectives of this study were to evaluate how educational
efforts would impact antimicrobial prescribing in the treat-
ment of urinary tract infections and whether the change
in prescribing habits would result in a change in bacterial
susceptibilities to quinolones within our hospitals.
Methods: Data was collected on all hospitalized patients
admitted with a diagnosis of urinary tract infections,
urosepsis, or pyelonephritis (n = 113) during January - May
2005. Antimicrobials selected for empiric and targeted
therapy were reviewed. Twenty-nine percent of community-
acquired infections and 41.2% of institutionally-acquired
infections were found to be resistant to the quinolones,
while only 15.6% and 17.1% of the respective infections
were resistant to cefazolin. The results were presented
to the Antibiotic Subcommittee of the Pharmacy & Thera-
peutics Committee, Emergency Medicine Department, and
hospitalists physician group. This was followed by an article
published in the physician newsletter on the management
of urinary tract infections. Empiric prescribing guidelines
encouraging the use of cefazolin were incorporated into
the system-wide antibiogram. Educational posters were
created and displayed at all of the nursing units and Emer-
gency Rooms. A follow-up study was conducted in January
- March 2007 (n = 75) to evaluate the impact of the educa-
tional efforts on antibiotic prescribing. Finally, the bacterial
susceptibilities were compared before and after the educa-
tional efforts.
Results: The empiric prescribing of quinolones for
the treatment of urinary tract infections, urosepsis, or
pyelonephritis decreased from 67.2% of patients in 2005
to 46.5% in 2007. The fraction of patients discharged on a
quinolone also decreased, 73% in 2005 to 47.7% in 2007. A
comparison of the 2005 to 2006 microbial data found that
there was a increase in the susceptibility of Pseudomonas
aeruginosa to quinolones from 65 -67% to 78% at PMC and
54% to 62% at POM, while there was no change in antimi-
crobial susceptibilities at PPH facilities that did not have an
educational program in place.
Conclusions: Educational efforts modestly improved the
selection of empiric antimicrobials in the treatment of
urinary tract infections at our community hospitals. Further-
more, the bacterial susceptibilities to the quinolones within
our hospitals improved.
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Is Ciproﬂoxacin Effective in the Treatment of Mycoplasma
Pneumonia? A Case Report
S. Kalimuddin ∗, M.L. Kang, B.H. Tan, J. Choo, H.N. Leong
Singapore General Hospital, Singapore, Singapore
A 22-year-old male army ofﬁcer cadet presented with a
three day history of high fever, cough with haemoptysis,
sore throat, myalgia and severe diarrhoea. Investiga-
tions on admission showed a normal total white cell
count, hyponatraemia, a raised creatine kinase, pyuria
and a normal chest radiograph. He was administered oral
ciproﬂoxacin for three days with no resolution of fever
or symptoms. Repeat chest radiograph done on Day 4 of
admission showed multilobar pneumonia with worsening of
laboratory results. Antibiotic therapy was changed to intra-
venous penicillin, ceftazidime and azithromycin. His fever
and symptoms resolved promptly within 48 hours. Subse-
quent serological studies revealed a nine-fold increase in
Mycoplasma pneumoniae antibody titre, and the patient
was diagnosed with Mycoplasma pneumonia. Ciproﬂoxacin
is generally considered as an effective treatment against
Mycoplasma pneumoniae based on in-vitro susceptibility
to ciproﬂoxacin. Till date there has been only one case
report of its effective use (Masayoshi et al. Antibiotics and
Chemotherapy. 18(12), p1835—1839 Japanese). This case
report is the ﬁrst in the literature to suggest clinical fail-
ure. Ciproﬂoxacin may not be effective in the treatment of
Mycoplasma pneumonia.
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Monitoring of Antibiotic Prophylaxis Usage in a Tertiary
Care Hospital
R. Adhikary ∗, B.N. Gokul, K.R. Kulkarni, M. Chakravarthy
Wockhardt Hospital, Bangalore, India
Background: It is a common knowledge that antibi-
otics are used indiscriminately. They should be used for
actual infections and not for colonization or prolonging the
